Maher Christopher, Feiner Benjamin, Baessler Kaven, Glazener Cathryn Ma
Wesley Urogynaecology Unit, Wesley Hospital, Sandford Jackson Building - Level 4, Suite 86, 30 Chasely Street, Auchenflower, Queensland, Australia, 4066.
Cochrane Database Syst Rev. 2010 Apr 14(4):CD004014. doi: 10.1002/14651858.CD004014.pub4.
Pelvic organ prolapse may occur in up to 50% of parous women. A variety of urinary, bowel and sexual symptoms may be associated with the prolapse.
To determine the effects of the many different surgeries used in the management of pelvic organ prolapse.
We searched the Cochrane Incontinence Group Specialised Register (9 February 2009) and reference lists of relevant articles. We also contacted researchers in the field.
Randomised or quasi-randomised controlled trials that included surgical operations for pelvic organ prolapse.
Trials were assessed and data extracted independently by two review authors. Six investigators were contacted for additional information with five responding.
Forty randomised controlled trials were identified evaluating 3773 women. Abdominal sacral colpopexy was better than vaginal sacrospinous colpopexy in terms of a lower rate of recurrent vault prolapse (RR 0.23, 95% CI 0.07 to 0.77) and less dyspareunia (RR 0.39, 95% CI 0.18 to 0.86). However there was no statistically significant difference in re-operation rates for prolapse (RR 0.46, 95% CI 0.19 to 1.11). The vaginal sacrospinous colpopexy was quicker and cheaper to perform and women had an earlier return to activities of daily living. The three trials contributing to this analysis were clinically heterogeneous.For anterior vaginal wall prolapse, standard anterior repair was associated with more recurrent cystoceles than when supplemented with a polyglactin mesh inlay (RR 1.39, 95% CI 1.02 to 1.90) or porcine dermis mesh inlay (RR 2.72, 95% CI 1.20 to 6.14); but data on morbidity and other clinical outcomes were lacking. Standard anterior repair was associated with more anterior compartment failures on examination than for polypropylene mesh repair as an overlay (RR 2.14, 95% CI 1.23 to 3.74) or armed transobturator mesh (RR 3.55, 95% CI 2.29 to 5.51). Data relating to polypropylene mesh overlay were extracted from conference abstracts without any peer reviewed manuscripts available and should be interpreted with caution. No differences in subjective outcomes, quality of life data, de novo dyspareunia, stress incontinence, re-operation rates for prolapse or incontinence were identified. Blood loss with transobturator meshes was significantly higher than for native tissue anterior repair. Mesh erosions were reported in 10% (30/293) of anterior repairs with polypropylene mesh.For posterior vaginal wall prolapse, the vaginal approach was associated with a lower rate of recurrent rectocele or enterocele, or both, than the transanal approach (RR 0.24, 95% CI 0.09 to 0.64); although there was a higher blood loss and post-operative narcotic use. No data exist on efficacy or otherwise of polypropylene mesh in the posterior vaginal compartment.Meta-analysis on the impact of continence surgery at the time of prolapse surgery was performed with data from seven studies. Continence surgery at the time of prolapse surgery in continent women did not significantly reduce the rate of post-operative stress urinary incontinence (RR 1.39, 95% CI 0.53 to 3.70; random-effects model).
AUTHORS' CONCLUSIONS: Abdominal sacral colpopexy was associated with a lower rate of recurrent vault prolapse and dyspareunia than with vaginal sacrospinous colpopexy. These benefits must be balanced against a longer operating time, longer time to return to activities of daily living and increased cost of the abdominal approach. The use of mesh or graft inlays at the time of anterior vaginal wall repair reduces the risk of recurrent anterior wall prolapse, on examination. Posterior vaginal wall repair may be better than transanal repair in the management of rectoceles in terms of recurrence of prolapse. The value of the addition of a continence procedure to a prolapse repair operation in women who are dry before operation remains to be assessed. Adequately powered randomised controlled clinical trials are urgently needed on a wide variety of issues and particularly need to include women's perceptions of prolapse symptoms.
多达50%的经产妇可能发生盆腔器官脱垂。脱垂可能伴有多种泌尿、肠道及性功能症状。
确定用于治疗盆腔器官脱垂的多种不同手术的效果。
我们检索了Cochrane尿失禁小组专业注册库(2009年2月9日)及相关文章的参考文献列表。我们还联系了该领域的研究人员。
包括盆腔器官脱垂手术的随机或半随机对照试验。
由两名综述作者独立评估试验并提取数据。联系了6名研究人员以获取更多信息,5人给予了回复。
共确定40项随机对照试验,涉及3773名女性。腹骶阴道固定术在降低穹隆脱垂复发率(RR 0.23,95%CI 0.07至0.77)及减少性交困难方面优于阴道骶棘韧带固定术(RR 0.39,95%CI 0.18至0.86)。然而,脱垂再次手术率无统计学显著差异(RR 0.46,95%CI 0.19至1.11)。阴道骶棘韧带固定术操作更快、费用更低,女性可更早恢复日常生活活动。纳入该分析的3项试验在临床方面存在异质性。对于阴道前壁脱垂,标准前壁修补术相比补充聚乙醇酸网片植入(RR 1.39,95%CI 1.02至1.90)或猪真皮网片植入(RR 2.72,95%CI 1.20至6.14),复发性膀胱膨出更多;但缺乏关于发病率及其他临床结局的数据。标准前壁修补术相比聚丙烯网片覆盖修补术(RR 2.14,95%CI 1.23至3.74)或带线闭孔肌网片修补术(RR 3.55,95%CI 2.29至5.51),检查时前盆腔失败更多。与聚丙烯网片覆盖相关的数据摘自会议摘要,无同行评审的手稿,应谨慎解读。在主观结局、生活质量数据、新发性交困难、压力性尿失禁、脱垂或尿失禁再次手术率方面未发现差异。闭孔肌网片修补术的失血量显著高于单纯组织前壁修补术。聚丙烯网片修补的前壁修补术中,10%(30/293)报告有网片侵蚀。对于阴道后壁脱垂,经阴道途径相比经肛门途径,直肠膨出或肠膨出或两者的复发率更低(RR 0.24,95%CI 0.09至0.64);尽管失血量更多且术后使用麻醉剂更多。关于聚丙烯网片在阴道后盆腔的疗效等尚无数据。对7项研究的数据进行了关于脱垂手术时同时进行控尿手术影响的Meta分析。在无尿失禁的女性中,脱垂手术时同时进行控尿手术并未显著降低术后压力性尿失禁的发生率(RR 1.39,95%CI 0.53至3.70;随机效应模型)。
腹骶阴道固定术相比阴道骶棘韧带固定术,穹隆脱垂复发率及性交困难更低。这些益处必须与手术时间更长、恢复日常生活活动时间更长及腹部手术费用增加相权衡。阴道前壁修补时使用网片或移植物植入可降低检查时前壁脱垂复发风险。在直肠膨出的治疗中,阴道后壁修补术在脱垂复发方面可能优于经肛门修补术。对于术前无尿失禁的女性,在脱垂修复手术中增加控尿手术的价值仍有待评估。迫切需要就各种问题开展有足够样本量的随机对照临床试验,尤其需要纳入女性对脱垂症状的认知情况。